Total Body Irradiation: Guidelines from the International Lymphoma Radiation Oncology Group (ILROG)

TY - JOUR

T1 - Total Body Irradiation

T2 - Guidelines from the International Lymphoma Radiation Oncology Group (ILROG)

AU - Wong, Jeffrey Y C

AU - Filippi, Andrea Riccardo

AU - Dabaja, Bouthaina Shbib

AU - Yahalom, Joachim

AU - Specht, Lena

N1 - Copyright © 2018 Elsevier Inc. All rights reserved.

PY - 2018/7/1

Y1 - 2018/7/1

N2 - Total body irradiation (TBI) remains an effective myeloablative treatment in regimens used for preparation and conditioning before allogeneic stem cell transplantation for leukemia. The regimens used vary across institutions in terms of dose, dose rate, fractionation, and technique. The objective of this document is to provide comprehensive guidelines for the current practice of delivering total body irradiation.

AB - Total body irradiation (TBI) remains an effective myeloablative treatment in regimens used for preparation and conditioning before allogeneic stem cell transplantation for leukemia. The regimens used vary across institutions in terms of dose, dose rate, fractionation, and technique. The objective of this document is to provide comprehensive guidelines for the current practice of delivering total body irradiation.

KW - Humans

KW - Internationality

KW - Lymphoma/radiotherapy

KW - Practice Guidelines as Topic

KW - Societies, Medical

KW - Whole-Body Irradiation/instrumentation

U2 - 10.1016/j.ijrobp.2018.04.071

DO - 10.1016/j.ijrobp.2018.04.071

M3 - Review

C2 - 29893272

SN - 0360-3016

VL - 101

SP - 521

EP - 529

JO - International Journal of Radiation Oncology, Biology, Physics

JF - International Journal of Radiation Oncology, Biology, Physics

IS - 3

ER -